ATP5IF1 and metastatic neoplasm: Mechanistically, the overexpression of IF1 in human hepatocarcinomas [20] activates the NFκB pathway and primes metastatic disease through Snai1- and VEGF-guided epithelial to mesenchymal transition (EMT) and angiogenesis, respectively.